← Leaderboards
Andre Rogatko
Fox Chase Cancer Center
$3,700,627
Attributed
$4,729,997
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $733K · FY2006–20$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,729,997 · 6
By mechanism
U01$2,058,741 · 1
P01$1,096,758 · 2
P50$1,013,562 · 1
P30$392,436 · 1
R03$168,500 · 1
Top collaborators
- Patricia A. Ganz3 shared
Most similar at Fox Chase Cancer Center
Same institution · by research overlap
- Louis M Weiner$35,160,146
- Robert C Young$34,163,223
- Michael F. Ochs$3,512,544
- Kenneth H Buetow$664,585
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelRandomizedBaseResourcesData ManagementProgramsReportingFutureClinical TrialsCollaborationsMalignant NeoplasmsEnsureDatabasesConsultInnovationManuscriptsComputer SoftwareDesignHealth Insurance Portability And Accountability ActCancer CenterBiometryAchievementBasic ScienceClinical Data
Grant awards (26)
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$666,397
U01 · FY2020 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$659,371
U01 · FY2019 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$732,973
U01 · FY2018 · CA · contact PI
Bioinformatics. Biostatistics. and Translational (BBT) Core$74,686
P01 · FY2013 · CA · contact PI
Bioinformatics. Biostatistics. and Translational (BBT) Core$93,395
P01 · FY2012 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT CORE$192,500
P50 · FY2011 · CA · contact PI
Bioinformatics. Biostatistics. and Translational (BBT) Core$96,802
P01 · FY2011 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT CORE$217,903
P50 · FY2010 · CA · contact PI
Biostatistics$149,041
P01 · FY2010 · CA · contact PI
Bioinformatics. Biostatistics. and Translational (BBT) Core$99,956
P01 · FY2010 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT CORE$213,380
P50 · FY2009 · CA · contact PI
Biostatistics$134,761
P01 · FY2009 · CA · contact PI
Bioinformatics. Biostatistics. and Translational (BBT) Core$101,689
P01 · FY2009 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT CORE$212,501
P50 · FY2008 · CA · contact PI
Biostatistics$132,148
P01 · FY2008 · CA · contact PI
BIOSTATISTICS AND DATA MANAGEMENT CORE$177,278
P50 · FY2007 · CA · contact PI
Biostatistics$132,183
P01 · FY2007 · CA · contact PI
Biostatistics$82,097
P01 · FY2006 · CA · contact PI
Etiology of Toxic Response to Cancer Treatment$84,000
R03 · FY2003 · CA
CORE--BIOSTATISTICS$196,218
P30 · FY2002 · CA
Etiology of Toxic Response to Cancer Treatment$84,500
R03 · FY2002 · CA
CORE--BIOSTATISTICS$196,218
P30 · FY2001 · CA
CORE--BIOSTATISTICS$0
P30 · FY2001 · CA
CORE--BIOSTATISTICS$0
P30 · FY2001 · CA
CORE--BIOSTATISTICS$0
P30 · FY2000 · CA
CORE--BIOSTATISTICS$0
P30 · FY2000 · CA